A Study of Rituximab in Frontline Therapy for Glomerulonephritis
Condition(s):GlomerulonephritisLast Updated:March 9, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):GlomerulonephritisLast Updated:March 9, 2023Recruiting
Condition(s):GlomerulonephritisLast Updated:July 20, 2021Unknown status
Condition(s):Glomerulonephritis AcuteLast Updated:July 29, 2022Active, not recruiting
Condition(s):Fibrillary GlomerulonephritisLast Updated:March 6, 2024Not yet recruiting
Condition(s):Glomerulonephritis AcuteLast Updated:November 14, 2023Completed
Condition(s):GlomerulonephritisLast Updated:April 5, 2016Completed
Condition(s):GlomerulonephritisLast Updated:November 14, 2012Terminated
Condition(s):Extracapillary GlomerulonephritisLast Updated:April 6, 2018Unknown status
Condition(s):Glomerulonephritis, MembranousLast Updated:December 12, 2019Completed
Condition(s):Primary GlomerulonephritisLast Updated:September 12, 2005Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.